Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Evidence-Based Complementary and Alternative Medicine, enter your email address in the box below.

Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 581260, 12 pages
http://dx.doi.org/10.1155/2015/581260
Research Article

Shuangshen Ningxin Capsule, a Traditional Chinese Medicinal Preparation, Alleviates Myocardial Ischemia through Autophagy Regulation

Jun Wang,1,2 Jincai Hou,1 Chengren Lin,1 Jianhua Fu,1 Jianxun Ren,1 Lei Li,1 Hao Guo,1 Xiao Han,1 Bing Wang,3 and Jianxun Liu1

1Institute of Basic Medical Sciences of Xiyuan Hospital, Beijing Key Laboratory of Pharmacology of Chinese Materia Medicine, 1 Xiyuan Caochang, Haidian District, Beijing 100091, China
2Institute of Basic Theory, China Academy of Chinese Medical Sciences, 16 Dong Zhi Men Nei Nan Xiao Jie, Beijing 100700, China
3Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA

Received 23 October 2014; Revised 31 December 2014; Accepted 31 December 2014

Academic Editor: Hyunsu Bae

Copyright © 2015 Jun Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. Viles-Gonzalez, S. X. Anand, C. Valdiviezo et al., “Update in atherothrombotic disease,” Mount Sinai Journal of Medicine, vol. 71, no. 3, pp. 197–208, 2004. View at Google Scholar · View at Scopus
  2. X.-H. Zhang, Z. L. Lu, and L. Liu, “Coronary heart disease in China,” Heart, vol. 94, no. 9, pp. 1126–1131, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. D. J. Rader and G. K. Hovingh, “HDL and cardiovascular disease,” The Lancet, vol. 384, no. 9943, pp. 618–625, 2014. View at Publisher · View at Google Scholar
  4. K. Sadamatsu, S. Koide, K. Nakano, and K. Yoshida, “Heart rate control with single administration of a long-acting β-blocker at bedtime before coronary computed tomography angiography,” Journal of Cardiology, 2014. View at Publisher · View at Google Scholar
  5. K. K. Sharma, M. Mathur, R. Gupta et al., “Epidemiology of cardioprotective pharmacological agent use in stable coronary heart disease,” Indian Heart Journal, vol. 65, no. 3, pp. 250–255, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. X.-L. Li, J.-X. Liu, and Y.-J. Guo, “Effect of Shuangshen Ningxin formula on energy metabolism of myocardial ischemia/reperfusion rats,” Zhongguo Zhong Yao Za Zhi, vol. 38, no. 17, pp. 2874–2877, 2013 (Chinese). View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Yu, J.-X. Liu, X.-Z. Li, X.-H. Shang, A.-G. Yan, and X.-Q. Feng, “Protective effects of Shuangshen Ningxin capsule on miniature swine after myocardial ischemia by intervention,” Zhongguo Zhongyao Zazhi, vol. 32, no. 16, pp. 1695–1699, 2007 (Chinese). View at Google Scholar · View at Scopus
  8. M. Wang, G.-B. Sun, X. Sun et al., “Cardioprotective effect of salvianolic acid B against arsenic trioxide-induced injury in cardiac H9c2 cells via the PI3K/Akt signal pathway,” Toxicology Letters, vol. 216, no. 2-3, pp. 100–107, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Wang, Y. Zhang, L.-L. Guo, G.-J. Wu, and R.-H. Liu, “Salvianolic acid B inhibits the TLR4-NFκB-TNFα pathway and attenuates neonatal rat cardiomyocyte injury induced by lipopolysaccharide,” Chinese Journal of Integrative Medicine, vol. 17, no. 10, pp. 775–779, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Glick, S. Barth, and K. F. Macleod, “Autophagy: cellular and molecular mechanisms,” Journal of Pathology, vol. 221, no. 1, pp. 3–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. X. H. Bao, Y. Naomoto, H. F. Hao et al., “Autophagy: can it become a potential therapeutic target?” International Journal of Molecular Medicine, vol. 25, no. 4, pp. 493–503, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Yamamoto, K.-I. Sawada, H. Shimomura, K. Kawamura, and T. N. James, “On the nature of cell death during remodeling of hypertrophied human myocardium,” Journal of Molecular and Cellular Cardiology, vol. 32, no. 1, pp. 161–175, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. M. W. M. Knaapen, M. J. Davies, M. de Bie, A. J. Haven, W. Martinet, and M. M. Kockx, “Apoptotic versus autophagic cell death in heart failure,” Cardiovascular Research, vol. 51, no. 2, pp. 304–312, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Shimomura, F. Terasaki, T. Hayashi, Y. Kitaura, T. Isomura, and H. Suma, “Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy,” Japanese Circulation Journal, vol. 65, no. 11, pp. 965–968, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Yan, D. E. Vatner, S.-J. Kim et al., “Autophagy in chronically ischemic myocardium,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 39, pp. 13807–13812, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. F. LoVerso, S. Carnio, A. Vainshtein, and M. Sandri, “Autophagy is not required to sustain exercise and PRKAA1/AMPK activity but is important to prevent mitochondrial damage during physical activity,” Autophagy, vol. 10, no. 11, pp. 1883–1894, 2014. View at Publisher · View at Google Scholar
  17. Y.-C. Su, X. Guo, and X. Qi, “Threonine 56 phosphorylation of Bcl-2 is required for LRRK2 G2019S-induced mitochondrial depolarization and autophagy,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1852, no. 1, pp. 12–21, 2015. View at Publisher · View at Google Scholar
  18. X. Li, J. Liu, L. Lin et al., “Traditional chinese medicine shuangshenningxin attenuates myocardial ischemia/reperfusion injury by preserving of mitochondrial function,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 180965, 10 pages, 2014. View at Publisher · View at Google Scholar
  19. L. M. Work, A. R. McPhaden, N. J. Pyne, S. Pyne, R. M. Wadsworth, and C. L. Wainwright, “Short-term local delivery of an inhibitor of ras farnesyltransferase prevents neointima formation in vivo after porcine coronary balloon angioplasty,” Circulation, vol. 104, no. 13, pp. 1538–1543, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Guarda, L. C. Katwa, S. E. Campbell et al., “Extracellular matrix collagen synthesis and degradation following coronary balloon angioplasty,” Journal of Molecular and Cellular Cardiology, vol. 28, no. 4, pp. 699–706, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Wang, J. Hou, P. Zhang, D. Li, C. Zhang, and J. Liu, “Geniposide reduces inflammatory responses of oxygen-glucose deprived rat microglial cells via inhibition of the TLR4 signaling pathway,” Neurochemical Research, vol. 37, no. 10, pp. 2235–2248, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Li, X. Han, J. C. Hou, and J. X. Liu, “Comparison of effects of Shuangshen Ningxin serum obtained from normal rat and myocardial ischemia rat on H/R H9C2 myocardial cells,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 17, no. 22, pp. 127–130, 2011 (Chinese). View at Google Scholar
  23. S. Vickers, C. A. Duncan, I.-W. Chen, A. Rosegay, and D. E. Duggan, “Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug,” Drug Metabolism and Disposition, vol. 18, no. 2, pp. 138–145, 1990. View at Google Scholar · View at Scopus
  24. A. M. Andres, G. Hernandez, P. Lee et al., “Mitophagy is required for acute cardioprotection by simvastatin,” Antioxidants & Redox Signaling, vol. 21, no. 14, pp. 1960–1973, 2014. View at Publisher · View at Google Scholar
  25. C. von Birgelen, W. Klinkhart, G. S. Mintz et al., “Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo,” Journal of the American College of Cardiology, vol. 37, no. 7, pp. 1864–1870, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Schoenhagen, K. M. Ziada, S. R. Kapadia, T. D. Crowe, S. E. Nissen, and E. M. Tuzcu, “Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study,” Circulation, vol. 101, no. 6, pp. 598–603, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. S. A. Zaitone and N. M. Abo-Gresha, “Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF,” European Journal of Pharmacology, vol. 691, no. 1–3, pp. 134–142, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Xu, P. J. Little, T. Lan et al., “Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in Apolipoprotein-E knockout mice fed a high cholesterol diet,” Archives of Biochemistry and Biophysics, vol. 515, no. 1-2, pp. 72–79, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Xu, Z. Liu, Y. Huang et al., “Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation,” Translational Research, vol. 160, no. 2, pp. 114–124, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Bao, L. Wang, Y. Xu et al., “Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner,” Atherosclerosis, vol. 223, no. 1, pp. 152–159, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Valentim, K. M. Laurence, P. A. Townsend et al., “Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury,” Journal of Molecular and Cellular Cardiology, vol. 40, no. 6, pp. 846–852, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Shen, C. Wang, F. Fan et al., “Acetaldehyde dehydrogenase 2 (ALDH2) deficiency exacerbates pressure overload-induced cardiac dysfunction by inhibiting Beclin-1 dependent autophagy pathway,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1852, no. 2, pp. 310–318, 2015. View at Publisher · View at Google Scholar
  33. Y. Matsui, H. Takagi, X. Qu et al., “Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and beclin 1 in mediating autophagy,” Circulation Research, vol. 100, no. 6, pp. 914–922, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Lewandrowski, A. Chen, and J. Januzzi, “Cardiac markers for myocardial infarction. A brief review,” The American Journal of Clinical Pathology, vol. 118, pp. S93–S99, 2002. View at Google Scholar
  35. S. M. Yang, J. Liu, and C. X. Li, “Intermedin protects against myocardial ischemia-reperfusion injury in hyperlipidemia rats,” Genetics and Molecular Research, vol. 13, no. 4, pp. 8309–8319, 2014. View at Publisher · View at Google Scholar